HopeStage
Back to all studies
CompletedNCT05220410

Psilocybin research for depression and persistent suicidal thoughts

About this titleRead the official source — NCT05220410

This study evaluated the safety and effectiveness of Psilocybin for people with depression.

Medication studyAges 18–65United States
The study in practice

Understand this study

What did researchers investigate?

This study evaluated the safety and effectiveness of Psilocybin for people with depression.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
BaltimoreSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: March 28, 2022
Recruitment status
Completed
Enrollment listed in the registry
20
Sponsor
Sheppard Pratt Health System
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT05220410
Official title
Show the full official title

The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

This study evaluated the safety and effectiveness of Psilocybin for people with depression.

Who is behind this study?

The study sponsor is Sheppard Pratt Health System.

Did this study involve medication?

Yes. The study involved medication, including Psilocybin.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies